I13300 - Urology

Mentor: John Knight, PhD, Department of Urology, 816 KHGB, 720 20th Street South, Birmingham AL 35249. Tel: 205-996-2295, Email: This email address is being protected from spambots. You need JavaScript enabled to view it. .

Postdoctoral positions are available to study the biology of Oxalobacter formigenes (Oxf). Lack of colonization with Oxf is a risk factor for recurrent calcium oxalate stone formation. The research is supported by the National Institutes of Health and involves work with both laboratory and gnotobiotic mice. The research will involve the use of several core facilities on the UAB campus. Fellows will normally have the opportunity to present their results at one national or international meeting each year. These positions offer careful mentoring to optimize skills in manuscript and grant preparation, knowledge acquisition and research techniques, and to enable the fellow to become a fully independent investigator. Candidates should have a PhD and/or MD degree and be able to provide evidence of their research capabilities and ability to be self-motivated. Prior experience in microbiology and molecular biology techniques would be an advantage.


Interested individuals should E-mail their CV, a statement of their research interests and career aspirations, and the names of three references to
This email address is being protected from spambots. You need JavaScript enabled to view it. . Further information may be obtained by E-mail or telephoning Dr.Knight at 205-996-2295.

 

 

 

 

 

UAB News

  • As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.

  • effrey R. Curtis, M.D., from the University of Alabama at Birmingham, and colleagues utilized 1998 to 2011 data from the U.S. Veterans Health Administration to identify RA patients initiating rituximab, abatacept, or anti-tumor necrosis factor (anti-TNF) therapy. The authors sought to assess the comparative risk of hospitalized infection associated with anti-TNF and non-anti-TNF biologic agents.

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...